SHARE

InnoStars, Education, Innovation, 2018

EIT Health community can attend 11-13 Oct. Semmering Symposium In Vienna at special rate

15th August 2019

EIT Health CEO and Board Members among panellists

Members of the EIT Health community can receive a €200 discount on their fees to attend the 11-13 October Semmering Symposium, a gathering of scientists, health industry experts and health policy stakeholders meeting in Vienna to discuss eco-systems that drive innovation in healthcare by fostering collaboration, research and entrepreneurship. EIT Health’s CEO and Board Members will be among the panellists.

The underlying theme of the symposium is “Biotech made in Vienna: From Landsteiner to global products for infectious disease control”.

It will utilise the successful example of how Vienna, driven by the creation of Campus Vienna Biocenter in 1987, has become an attractive and respected venue for biotech enterprises, and a globally leading centre for vaccine innovation.

EIT Health Supervisory Board Chairman Alexander von Gabain and CEO Jan-Philipp Beck, as well as other members of the EIT Health Supervisory Board, will be panelists for the symposium. The symposium is organised by Vienna Vaccines, an independent non-profit organisation devoted to building networks in the vaccine and biotech sector.

Given the many connections between this event and the mission and work of our network, EIT Health will subsidise the attendance of members of our community who wish to attend. To attend the event at a discounted price of €500, or to attend and receive accommodation at a discounted price of €900, please register by filling out this form, and add the words “EIT Health” in the line that says “Special Rate Code”.

EIT Health Catapult 2021 selects 42 semi-finalists

EIT Health Catapult 2021 selects 42 semi-finalists

Learn about these promising start-ups

Find out more

EIT Health partners Warsaw Health Innovation Hub

EIT Health partners Warsaw Health Innovation Hub

A joint initiative between government and business

Find out more

Will COVID-19 spark a cancer vaccine boom?

Will COVID-19 spark a cancer vaccine boom?

Using DNA vaccines to fight cancer

Find out more